BIO, E&Y Lead Private Sector Initiative to Provide Biotechnology Resources for the Federal JudiciaryFeb 20 2002
New York (February 20, 2002)-Judges, lawyers and scientists are challenged with complex and novel legal issues surrounding cutting-edge biotechnology research and development, and related health... |
|
2002 Helix Award to be Presented at BIO CEO & Investor ConferenceFeb 15 2002
Washington, D.C. (February 15, 2002) – The seventh annual Helix Award will be presented on February 21 at the Biotechnology Industry Organization’s CEO & Investor Conference at the Waldorf-Astoria... |
|
Industry Experts Announced for BIO’s Investor ConferenceFeb 14 2002
Washington, D.C. (February 14, 2002) - The Biotechnology Industry Organization (BIO) today announced the names of industry leaders who will participate in the opening and closing plenary sessions... |
|
Nobel, Pulitzer Prize Winners To Address Biotech Conference in New YorkFeb 13 2002
Washington, D.C. (February 13, 2002) – The Biotechnology Industry Organization (BIO) today announced that Dr. Harold Varmus, recipient of the Nobel Prize in medicine and former director of... |
|
Christopher Reeve to Speak at BIO’s CEO & Investor ConferenceFeb 12 2002
Washington, D.C. (February 12, 2002) - Christopher Reeve, the actor, director and patients’ rights advocate, will participate in a panel discussion on stem cells and human cloning issues on... |
|
Proposed Hike in User Fees Unfair Burden for Biotech CompaniesFeb 8 2002
WASHINGTON, D.C. – (February 8, 2002) – Biotechnology Industry Organization President Carl B. Feldbaum described the $272 million in user fees included in the proposed FY2003 Food and... |
|
BIO CEO & Investor Conference 2002 Spotlights Industry LeadersFeb 5 2002
Washington, D.C. (February 5, 2002)- The Biotechnology Industry Organization (BIO) today announced the names of the biotechnology companies selected to present at its fourth annual CEO & Investor... |
|
FDA Approves 16 New Biotech Products, Eight New Indications in 2001Feb 4 2002
Washington, D.C. (February 4, 2002) – The FDA approved 16 new biotechnology-based medicines and vaccines in 2001, as well as eight new indications for previously approved biotech products,... |
|
BIO 2002 Media Registration OpensJan 30 2002
WASHINGTON, DC – (January 30, 2002) – Advance media registration for the 16th annual BIO 2002 International Convention and Exhibition is now available. The meeting will be held June 9 – 12, 2002... |
|
BIO Supports NAS FindingsJan 18 2002
WASHINGTON, D.C. - (January 18, 2002) - Biotechnology Industry Organization Vice President for Bioethics Michael Werner released the following statement on the National Academy of Science’s... |
